Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 3552)
Milan 20133
1 studies enrolling now · 1 studies all time
What they study most
Malignant Neoplasm
Studies at this site
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
— Recruiting now